Text this: An Integrated Machine-Learning and Reverse Network-Pharmacology Pipeline Reveals JUN /C3 Candidate Biomarkers and an Anti-Fibrotic Mechanism of Resveratrol via MAPK/JNK Signaling in Chronic Kidney Disease.